Designed With Good Intentions, Built With Blind Spots: How Modern Prescription Packaging Is Failing the Patients Who Need It Most

Every year, American pharmacies dispense more than four billion prescriptions. Each one arrives in a container that has been shaped, to some degree, by decades of regulatory guidance, liability concerns, and safety mandates. The amber plastic bottle with its childproof cap has become so familiar that most patients never think twice about it. But for a growing segment of the population, that container is not a neutral vessel — it is a daily obstacle, and sometimes a genuine hazard.

Recent modifications to prescription packaging, including updated child-resistant closure standards, revised labeling formats, and new color-coded systems introduced by large pharmacy chains, were conceived with patient safety in mind. What regulators and retail pharmacy executives did not always anticipate was how those changes would interact with the realities of aging, chronic illness, and sensory impairment. The result, as pharmacists and patient advocates are increasingly willing to say aloud, is a system that protects certain patients while quietly failing others.

The Child-Resistant Cap Problem Is Not New — But It Is Getting Worse

The Poison Prevention Packaging Act of 1970 mandated child-resistant closures on most prescription medications, and by virtually every measure, that legislation saved lives. Childhood poisoning deaths from medications dropped dramatically in the decades that followed. The policy was, and remains, a public health success.

But success in one population does not guarantee safety across all populations. The same closure mechanisms that prevent a curious four-year-old from accessing a bottle of oxycodone can make it functionally impossible for a seventy-eight-year-old woman with rheumatoid arthritis to access her methotrexate on schedule.

Patients do have the legal right to request non-child-resistant packaging, and pharmacists are required to honor that request. The problem is that many patients — particularly those who are older, newly diagnosed, or navigating a new pharmacy — are never told this option exists. A 2021 survey published in the Journal of the American Pharmacists Association found that fewer than one in three older adults with documented dexterity limitations had ever been informed by a pharmacist that alternative closures were available.

When patients cannot open their bottles reliably, they do not always ask for help. They skip doses. They transfer medications into easier containers — sometimes ones without labels, sometimes ones that belong to other drugs. They improvise in ways that introduce entirely new safety risks.

Labeling Reforms That Reduced Clarity Instead of Improving It

In an effort to improve medication literacy, several major pharmacy chains rolled out redesigned label formats over the past decade. The intention was laudable: reduce medical jargon, increase font size, organize information more intuitively. Some of these redesigns did improve comprehension for certain patients.

Others introduced new problems. Color-coded systems, for instance, are entirely inaccessible to patients with color vision deficiency — a condition affecting approximately eight percent of men and half a percent of women in the United States. When a label uses a red band to signal a high-alert medication or a yellow band to indicate a drug requiring food, that information is simply invisible to a meaningful portion of the patient population.

Font size increases, while helpful in theory, sometimes compressed critical information into smaller spaces when label dimensions were not correspondingly adjusted. Instructions that once read clearly became truncated or repositioned in ways that disrupted reading order. For patients with low vision who rely on a predictable label structure, these changes required relearning a system they had previously navigated successfully.

Dr. Renata Holloway, a clinical pharmacist with more than twenty years of experience in geriatric care settings in the Chicago area, describes the situation plainly: "We keep redesigning the label without adequately testing it on the people who are most dependent on it. Older adults, patients with low vision, patients managing multiple chronic conditions — these are the highest-volume prescription users in the country, and they are consistently underrepresented in packaging usability studies."

The Polypharmacy Dimension

The packaging problem compounds significantly for patients managing multiple medications simultaneously. According to data from the Centers for Disease Control and Prevention, nearly forty percent of adults over sixty-five take five or more prescription medications. For this population, prescription bottles are not individual objects — they are a system that must be navigated as a whole.

When that system lacks consistent visual differentiation, errors become more likely. Bottles of similar size and shape, bearing labels with similar formatting, filled with tablets that may look nearly identical to one another, create conditions in which even highly attentive patients make mistakes. Studies examining medication errors in community-dwelling older adults consistently identify visual confusion among containers as a contributing factor.

Some pharmacies have begun offering blister pack dispensing or multi-dose packaging as alternatives, and for certain patients these formats represent a meaningful improvement. But they are not universally available, are sometimes associated with additional cost, and may not be appropriate for medications requiring specific storage conditions.

Solutions That Already Exist — and Are Not Being Used at Scale

The frustrating reality is that many of the tools needed to address these problems are already available. Easy-open caps, as noted above, can be requested at virtually any pharmacy in the United States at no additional charge. Large-print labels can be printed on request at many retail pharmacy locations. Talking prescription labels — devices that attach to standard bottles and deliver audio instructions when activated — have been available for years and are offered free of charge through programs run by several major pharmacy chains, including CVS and Walgreens.

Audio label programs, in particular, have shown genuine promise. A study conducted at the University of California San Francisco found that patients using talking labels demonstrated significantly improved medication adherence and a reduced rate of dosing errors compared to patients using standard printed labels alone. Yet awareness of these programs remains low, and uptake is correspondingly limited.

Accessibility advocates argue that the core issue is structural: accommodations are available, but they require patients to know what to ask for, to feel empowered enough to ask, and to encounter a pharmacist or pharmacy technician who has time to explain the options. In high-volume retail pharmacy environments, those conditions are not reliably present.

What Patients and Caregivers Can Do Right Now

While systemic change moves slowly, there are practical steps patients can take immediately to reduce packaging-related medication risks.

First, speak directly with your pharmacist about closure preferences. If child-resistant caps are difficult to manage, request easy-open alternatives and ask that this preference be noted in your pharmacy profile so it applies to future prescriptions automatically.

Second, ask about large-print or audio label options. These services exist and are underutilized. A brief conversation at the pharmacy counter can make a significant difference in day-to-day medication management.

Third, if you are managing multiple medications and find the bottles difficult to distinguish from one another, consider using a pill organizer with clearly labeled compartments as a secondary system — while retaining the original bottles for reference.

Finally, if you are a caregiver for an older adult or a patient with visual or dexterity limitations, consider accompanying them to the pharmacy for a medication review. A pharmacist who understands the specific physical challenges a patient faces is far better positioned to recommend appropriate packaging accommodations.

The Broader Obligation

Prescription packaging is a patient safety issue, not a cosmetic one. When a container design prevents consistent, accurate medication use, it contributes directly to adverse outcomes — missed doses, dosing errors, preventable hospitalizations. The populations most affected are also the most medically vulnerable.

Regulatory bodies and pharmacy systems have a responsibility to evaluate packaging not only for what it prevents in the best-case scenario, but for what it causes in the populations that struggle with it most. Until usability testing routinely includes older adults, patients with low vision, and individuals with limited dexterity, well-intentioned design changes will continue to carry unintended costs — paid, as always, by patients.